Top Markets
Coin of the day
Alar Pharmaceuticals Inc. Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.

6785
Classement en actions #18601
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Prix de l'action
$2.88
Capitalisation boursière
$192.66M
Changement (1 jour)
-0.55%
Changement (1 an)
-59.61%
Pays
TW
Échange Alar Pharmaceuticals Inc. (6785)

Catégorie

Ratio P/S pour Alar Pharmaceuticals Inc. (6785)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Alar Pharmaceuticals Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Alar Pharmaceuticals Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes